However, in human cancer, MTBP is amplified and/or overexpressed in a range of malignancies, including lymphomas, carcinomas, and sarcomas, suggesting it is oncogenic in multiple tissue types [22, 23, 33]. The gene discussed is MTBP; the disease is lymphoma.